BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11357953)

  • 1. Superoxide stress identifies neurons at risk in a model of ataxia-telangiectasia.
    Quick KL; Dugan LL
    Ann Neurol; 2001 May; 49(5):627-35. PubMed ID: 11357953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice.
    Kamsler A; Daily D; Hochman A; Stern N; Shiloh Y; Rotman G; Barzilai A
    Cancer Res; 2001 Mar; 61(5):1849-54. PubMed ID: 11280737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ataxia-telangiectasia, an evolving phenotype.
    Chun HH; Gatti RA
    DNA Repair (Amst); 2004; 3(8-9):1187-96. PubMed ID: 15279807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The appropriateness of the mouse model for ataxia-telangiectasia: neurological defects but no neurodegeneration.
    Lavin MF
    DNA Repair (Amst); 2013 Aug; 12(8):612-9. PubMed ID: 23731731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional expression of ATM gene carried by HSV amplicon vector in vitro and in vivo.
    Qi J; Shackelford R; Manuszak R; Cheng D; Smith M; Link CJ; Wang S
    Gene Ther; 2004 Jan; 11(1):25-33. PubMed ID: 14681694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular perspectives on cancer, the cell cycle and the inherited disorder ataxia-telangiectasia.
    Brown KD; Tagle DA
    Prog Clin Biol Res; 1997; 396():101-13. PubMed ID: 9108592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased chromosome instability dramatically disrupts neural genome integrity and mediates cerebellar degeneration in the ataxia-telangiectasia brain.
    Iourov IY; Vorsanova SG; Liehr T; Kolotii AD; Yurov YB
    Hum Mol Genet; 2009 Jul; 18(14):2656-69. PubMed ID: 19414482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical spectrum of ataxia-telangiectasia in adulthood.
    Verhagen MM; Abdo WF; Willemsen MA; Hogervorst FB; Smeets DF; Hiel JA; Brunt ER; van Rijn MA; Majoor Krakauer D; Oldenburg RA; Broeks A; Last JI; van't Veer LJ; Tijssen MA; Dubois AM; Kremer HP; Weemaes CM; Taylor AM; van Deuren M
    Neurology; 2009 Aug; 73(6):430-7. PubMed ID: 19535770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atm expression patterns suggest a contribution from the peripheral nervous system to the phenotype of ataxia-telangiectasia.
    Soares HD; Morgan JI; McKinnon PJ
    Neuroscience; 1998 Oct; 86(4):1045-54. PubMed ID: 9697112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of an ataxia-telangiectasia gene to chromosome 11q22-23.
    Gatti RA; Berkel I; Boder E; Braedt G; Charmley P; Concannon P; Ersoy F; Foroud T; Jaspers NG; Lange K
    Nature; 1988 Dec; 336(6199):577-80. PubMed ID: 3200306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton MR spectroscopic imaging in ataxia-telangiectasia.
    Lin DD; Crawford TO; Lederman HM; Barker PB
    Neuropediatrics; 2006 Aug; 37(4):241-6. PubMed ID: 17177151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ataxia telangiectasia: a review.
    Rothblum-Oviatt C; Wright J; Lefton-Greif MA; McGrath-Morrow SA; Crawford TO; Lederman HM
    Orphanet J Rare Dis; 2016 Nov; 11(1):159. PubMed ID: 27884168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between DNA damage response and the central carbon metabolic network underlies selective vulnerability of Purkinje neurons in ataxia-telangiectasia.
    Sun JK; Wong GC; Chow KH
    J Neurochem; 2023 Aug; 166(4):654-677. PubMed ID: 37319113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ataxia telangiectasia.
    Nissenkorn A; Ben-Zeev B
    Handb Clin Neurol; 2015; 132():199-214. PubMed ID: 26564081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfunction of cerebellar microglia in Ataxia-telangiectasia.
    Levi H; Bar E; Cohen-Adiv S; Sweitat S; Kanner S; Galron R; Mitiagin Y; Barzilai A
    Glia; 2022 Mar; 70(3):536-557. PubMed ID: 34854502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A patient-derived olfactory stem cell disease model for ataxia-telangiectasia.
    Stewart R; Kozlov S; Matigian N; Wali G; Gatei M; Sutharsan R; Bellette B; Wraith-Kijas A; Cochrane J; Coulthard M; Perry C; Sinclair K; Mackay-Sim A; Lavin MF
    Hum Mol Genet; 2013 Jun; 22(12):2495-509. PubMed ID: 23474819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rat model of ataxia-telangiectasia: evidence for a neurodegenerative phenotype.
    Quek H; Luff J; Cheung K; Kozlov S; Gatei M; Lee CS; Bellingham MC; Noakes PG; Lim YC; Barnett NL; Dingwall S; Wolvetang E; Mashimo T; Roberts TL; Lavin MF
    Hum Mol Genet; 2017 Jan; 26(1):109-123. PubMed ID: 28007901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of DNA damage and reduced levels of nicotine adenine dinucleotide in the brains of Atm-deficient mice.
    Stern N; Hochman A; Zemach N; Weizman N; Hammel I; Shiloh Y; Rotman G; Barzilai A
    J Biol Chem; 2002 Jan; 277(1):602-8. PubMed ID: 11679583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cerebellar degeneration in ataxia-telangiectasia: A case for genome instability.
    Shiloh Y
    DNA Repair (Amst); 2020 Nov; 95():102950. PubMed ID: 32871349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegeneration in ataxia telangiectasia: what is new? What is evident?
    Hoche F; Seidel K; Theis M; Vlaho S; Schubert R; Zielen S; Kieslich M
    Neuropediatrics; 2012 Jun; 43(3):119-29. PubMed ID: 22614068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.